MicroPlanet to Exhibit at Top Energy Efficiency Conference

MicroPlanet Technology Corp.
TSXV: MP

OTC Pink: MCTYF
Shares Outstanding: 100.8 million
Fully Diluted: 155.8 million
-------------------------------

NAESCO or The National Association of Energy Service Companies is a national trade association, which promotes the benefits of energy efficiency. Each year NAESCO holds a conference and this year MicroPlanet is sending Brett Ironside, President & CEO and Alan Richardson, industry heavy weight & Director of MicroPlanet to exhibit and rub shoulders with the who’s who in the energy efficiency sector.

The conference is being held at the Hilton San Diego Resort & Spa in San Diego, CA between October 31 & November 2.

Click here for a list of exhibitors

Sponsors for the event includes: ConEdison Solutions, Synergy Companies, Philips & Aecom

Today’s news release also outlines the extension of maturity on the remaining portion of the company’s convertible notes by one year to October 14, 2012. During 2009, the Company closed a total of C$4,000,000 in convertible notes. These convertible notes were closed in three separate tranches beginning in June and completed in October. During the second quarter of this year, the Company renegotiated maturity and conversion terms with the holders of the convertible notes maturing during the Quarter. A total of C$2,737,000 of the face value of the Notes were due and payable by June 30, 2011. With the approval of the TSX Venture Exchange, holders of C$1,462,000 face value elected to convert their Notes to common shares of the Company at a rate of C$0.10 per share, including a warrant to purchase common shares of the Company at C$0.15 per share for a period of 24 months from closing. A total of C$875,000 face value elected to extend the maturity of their notes until June 30, 2012. A total of C$400,000 face value was redeemed for cash.

To view the full news release, please click here

Solid Resources Issues NI 43-101 on Southern Most Section of Rare Metals Property

Solid Resources
TSXV - SRW
OTCQX - SLDRF
Shares Outstanding - 93.9 million
Fully Diluted - 147.3 million
---------------------------------------

Today Solid Resources announced the NI 43-101 reserve results for its southern most (Toboazas) section of its Doade Presqueiras property in Spain.

Below is a table with the tonnage and average grades of Tantalum, tin, Lithium and Niobium.

Class.	Tonnes Mt	Ta2O5 Tantalum ppm	Sn Tin ppm	Li20 Lithium %	Nb2O5 Niobium ppm
Indicated	0.2	150.8	708.2	0.81	115.3
Inferred	4.0	144.7	646.1	0.77	109.2

Yesterday the company announced the NI 43-101 results for the northernmost section of the property. The results are below.

Class.	Tonnes Mt	Ta2O5 Tantalum ppm	Sn Tin ppm	Li20 Lithium %	Nb2O5 Niobium ppm
Measured	0.2	79.7	584.8	0.55	79.8
Indicated	1.4	86.1	584.1	0.43	80.2
Inferred	4.0	93.0	593.6	0.35	84.9

When figuring the value of the results, consider the following - 1 ppm= 1 g/t; 1% = 22.04 lbs.

Current prices of metals: Tin - $10/lb; Tantalum (Ta₂O₅) - $250/lb; Lithium (Li₂O)- $2-3/lb; Niobium (Nb₂O₅) - $24/lb

Also when considering the potential value of the property, understand that these results only represent a drilling done on less than 10% of the concession. Solid’s Management and Geological team believes the mineralization is approximately 250 – 250 m wide and runs the full length of the 14 km property. The results from the NI43-101 are only from the northernmost and southernmost sections.

Investors can expect the release of a metallurgical study on the results in the coming months.

To view the full news release, please click here

Solid Resources Advances Case For Open Pit Mine On Spanish Property With Release Of Initial Reserve Report

Solid Resources
TSXV - SRW
OTCQX - SLDRF
Shares Outstanding - 93.9 million
Fully Diluted - 147.3 million
---------------------------------------

Today’s news on the NI 43-101 reserve results for Solid’s northern most (Presqueiras) section of its Doade Presqueiras property in Spain adds weight to management’s objective of opening the first tantalum mine in Europe. A second release on NI 43-101 results for the southern most (Toboazas) area will be issued in the near future.

The data was accumulated from 29 drill holes from a 2003, 2005 and this year’s program. In total, 3,105.9 meters were drilled on a small section of the property being an area only 750 m x 350 m.

Greg Pendura, President and CEO of Solid was quoted in the release, "All drill programs to date have allowed management to conclude that the rare element pegmatites (the type of rock that hosts rare metals) are in a continuous belt approximately 300 m wide and extend the length of the 14 km property in a NNW-SSE direction."

Below is a table with the tonnage and average grades of Tantalum, tin, Lithium and Niobium.

Click on the table to enlarge.

1 ppm= 1 g/t; 1% = 22.04 lbs.

Current prices of metals: Tin - $10/lb; Tantalum (Ta2O5) - $250/lb; Lithium (Li2O)- $2-3/lb; Niobium (Nb2O5) - $24/lb

Management has publically stated that considering the near surface mineralization and its location, this area will be well suited for an open pit, low cost mining operation.

The obvious investor question is, what is the preliminary value of the rock? Simply, management is not allowed to discuss that question at this point under the regulatory environment. However, there’s nothing stopping anyone from doing their own calculations based on the above table.

To view the full news release, please click here

11th Installation For Ventripoint’s 3D Heart Imaging System – But Also A First!

VentriPoint Diagnostics Ltd.
VPT - TSX Venture
Shares issued: - 102.6 million
Fully diluted: - 134.0 million

*****************************

Today’s announcement had special significance as this installation was completed in an adult hospital, rather than a paediatric institution. The sale of the VMS™ technology to leading cardiac institution, Manchester Heart Center in northwest England is the eleventh. It is considered a ‘working site’ as the system will be used in regular clinical practice and as a demonstration site to prove the value of VMS in valve replacements and all of Manchester’s 20,000 patients with heart disease.

The Manchester Royal infirmary is a leading teaching school and part of Manchester University’s Medical School. The hospital has been around since 1752 with twelve beds and today is a major provider of cardiac services seeing over 145,000 patients per year.

Installations like this are very important to VentriPoint as they:

1. Generate publications by leading cardiology groups showing the VMS is as accurate to MRI, but faster, more convenient and can be done on awake patients.

2. Use these sites as demonstration sites for other cardiologists who are interested but would like to see a machine in use and speak with specialists.

3. Build close relationships with thought leaders to determine additional applications for the technology.

4. Have the users talk to large ultrasound companies (GE, Phillips, Siemens, Toshiba, Samsung) about the value of the technology.

5. Assist numerous people with heart disease who are unnecessarily waiting for MRIs.

VentriPoint currently has 230 cardiologists who have indicated they would be interested in potentially acquiring a VMS system. This "sales funnel" is quite large for such a small company.

To view the full news release, Click here

Neptune Conference Call Summary – Q2 Results, Chinese JV, Bayer, and more

Neptune Technologies & Bioressources
TSXV: NTB - NASDAQ: NEPT
Basic Shares: 48.2 million
Fully diluted: 53.9 million

**************************

At 4:30pm ET today (Oct. 13th), Neptune Technologies hosted an investor conference call to discuss Q2/F12 quarterly results and to discuss a number to items on the minds of investors.

Here’s a summary of the call.

Q2 Results: For the six months ending August 31, 2011 revenue was up slightly (4%), and the company had a net loss of just over $3 million.

• Andre Godin, CFO for Neptune explained that this was mainly a result of Acasti’s R&D activities.
• If that were removed, Neptune alone would be profitable.
• He also stated that next quarter revenue should be $5+ million but R&D expenses will remain for the next few quarters.
• The company increased product volume by 50% with EKO, the economic lower margin krill product versus NKO, accounting for 31%. According to Mr. Godin, the lack of increase in revenue is attributed to weak margins and the aggressive push to grab market share and expand in the US.

U.S. product push: The company said its deal with a new major US distributer is leading to NTB products now hitting the shelves of major retailers like WalMart and Walgreens.

Expansion: The company is expecting to increase capacity from 150Kg/yr to 300Kg/yr in the next year.

• An announcement should be coming soon for its new plant, which will support 200Kg-300Kg/yr. It will be paid for with a bank loan and government grants.

Chinese JV Partne – SKFC: The company said that is will give them access to the entire Asian market.

• SKFC is the largest krill fisher in the world.
• A plant will be built and financed by Chinese banks and Chinese partners.
• Neptune is to receive an upfront payment that “just about covers’ its financial commitment to the JV.

Nestle/Bayer: According to management the halt of sale through Bayer’s website was a result of Bayer wishing to reformulate and provide a new look to the product.

• The relationship with Bayer is strong. The halt was not a result of quality or inability to supply the product.
• The results of the Nestle clinical trial should be released by the end of this year.

NeuroBioPharm spinoff: According to management, it is taking time because it is more complicated than expected.

TSX: The company is expecting to migrate to the TSX from the Venture exchange within a month.

Capre Clinical Trials: Expected to have results within 12-18 months.

Patent: The company said at the end of the call that Neptune believes that the recently granted US patent is strong and valid. The company stands by it and are prepared to enforce it.

To hear an encore version of the Neptune conference call visit www.neptunebiotech.com by 6pm Eastern Time.

Solid - 2011 Drilling Confirms Over 11 KM of Continuous Mineralised Dykes

Solid Resources

TSXV - SRW
OTCQX - SLDRF
Shares Outstanding - 93.9 million
Fully Diluted - 147.3 million

-----------------------------------------

Tin, Tantalum, Lithium, Niobium, Rubidium & Cesium

Today Solid Resources highlighted its 2011 Drill Program on its 100% owned Doade-Presqueiras rare metals property in Spain.

In the news release Greg Pendura, President & CEO of Solid Resources talks about the company’s unique position to “become a non-conflict provider of tantalum and at the same time develop the first tantalum mine in Europe.”

At approximately $250/lb ($150/lb concentrate), Tantalum is a rare metal that is found in a vast majority of modern electronics. Tantalum has made worldwide headlines as it is classified as a “Conflict Mineral”, which are minerals mined in conditions of armed conflict and human rights abuses. Notably in the eastern provinces of the Democratic Republic on the Congo. The United States passed a law in July 2010 which prohibits American companies from purchasing “Conflict Minerals”.

Management also mentions in the release that Spain (a stable country) has been a supporter of Solid’s efforts. It has granted Solid Resources the maximum subsidy of 20% for work being done in the county.

Drilling Highlights

With the results now available the expected average contents of the deposit can be estimated in the order of 150 g/T of tantalum, 800 g/T of tin and approximately 1% of lithium.

The maximum grades found have been: 293 ppm tantalum, 2,930 ppm tin, 191 ppm niobium and more than 2% of lithium.

Next steps for the company Is the completion of a NI43-101 resource estimate and a metallurgical study during Q4 2011.

View 3D Animations of drilling on the Presqueiras (Northern-most) & Taboazas (Southern-most) sections of Spanish Rare Metals property.

To view the full news release, click here

Neptune Releases Conference Call Details

Neptune Technologies & Bioressources
TSXV: NTB - NASDAQ: NEPT
Basic Shares: 48.2 million
Fully diluted: 53.9 million

**************************


Today, Neptune announced that it will be holding a conference call and webcast this Thursday, October 13, 2011 at 4:30 pm ET.

According to the news release topics to be discussed on the call include:
-- Second quarter and year-to-date financial results,
-- An update on commercial progress,
-- Plans for production expansion,
-- The recently announced Neptune-SKFC Chinese Joint Venture for Asian expansion.

Investors will also be looking for more insight into the recent news on the US Patent and Trademark Office granting Neptune the patent for a main ingredient found in “all recognized krill oils.”

The webcast can be accessed in listen‐only mode free of charge, by clicking the link below:
http://bit.ly/mRGMep

To access the conference call by phone within Canada & the U.S. the toll‐free number is 1‐877-380-5664. Outside Canada and the U.S., dial 1‐631-813-4882.

Callers should dial in five to 10 minutes prior to the scheduled start time and ask to be connected to the "Neptune call."

Management will accept questions by telephone and e‐mail. Questions can be forwarded in advance or during the presentation to a.godin@neptunebiotech.com.

An archived recording of the webcast will be available on Neptune's website (www.neptunebiotech.com) two hours after the webcast.

Neptune’s Aggressive Stance - Defending Its Patent

Neptune Technologies & Bioressources
TSXV: NTB - NASDAQ: NEPT
Basic Shares: 48.2 million
Fully diluted: 53.9 million

**************************

Today, Neptune Technologies announced it launched multiple infringement actions against a number of krill oil companies distributing and selling in the United States. The legal actions follow yesterday’s announcement that the United States Patent and Trademark Office granted Neptune the patent which protects the Omega-3 composition of Neptune Krill Oil(TM) (NKO(R). The patent also “covers amongst others, oils and powders extracted from krill, containing marine phospholipids bonded to EPA and/or DHA, distributed and/or sold in the U.S. market.”

In the news release, Neptune names the companies which it has issued complaints against: Aker Biomarine ASA, Aker Biomarine Antarctic USA, Inc., Schiff Nutritional International, Enzymotec Limited., Enzymotec USA, Inc., Mercola.com Health Resources, LLC and Azantis, Inc.

Based on investor postings in the online world, there is satisfaction being expressed but a key question is, how long these actions will take and speculation on an eventual outcome. There is no definitive answer. This recent news appears to have provided some stability to the stock price, which as of this writing is trading in the $2.50 to $2.60 (CDN) range.

To view today’s news release, please click here.